Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation
Authors:
- 13 June 2007
- journal article
- review article
- Published by Wiley in Liver International
- Vol. 27 (7) , 879-890
Abstract
Liver disease afflicts over 10% of the world population. This includes chronic hepatitis, alcoholic steatosis, fibrosis, cirrhosis and hepatocellular carcinoma (HCC), which are the most health‐threatening conditions drawing considerable attention from medical professionals and scientists. Patients with alcoholism or viral hepatitis are much more likely to have liver cell damage and cirrhosis, and some may eventually develop HCC, which is unfortunately, and very often, a fatal malignancy without cure. While liver surgery is not suitable in many of the HCC cases, patients are mostly given palliative support cares or transarterial chemoembolization or systemic chemotherapies. However, HCC is well known to be a highly chemoresistant tumour, and the response rate is <10–20%. To this end, alternative medicines are being actively sought from other sources with hopes to halt the disease's progression or even eliminate the tumours. Traditional Chinese herbal medicine has begun to gain popularity worldwide for promoting healthcare as well as disease prevention, and been used as conventional or complementary medicines for both treatable and incurable diseases in Asia and the West. In this article, we discuss the laboratory findings and clinical trial studies of Chinese herbal medicines (particularly small molecule compounds) for the treatment of liver disease ranging from fibrosis to liver cancer.Keywords
This publication has 75 references indexed in Scilit:
- A Long-Term Glycyrrhizin Injection Therapy Reduces Hepatocellular Carcinogenesis Rate in Patients with Interferon-Resistant Active Chronic Hepatitis C: A Cohort Study of 1249 PatientsDigestive Diseases and Sciences, 2006
- Anti-inflammatory Effect of Pitavastatin on NF-.KAPPA.B Activated by TNF-.ALPHA. in Hepatocellular Carcinoma CellsBiological and Pharmaceutical Bulletin, 2006
- The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosisApoptosis, 2005
- Regulatory role of vHL/HIF-1α in hypoxia-induced VEGF production in hepatic stellate cellsBiochemical and Biophysical Research Communications, 2004
- Progress of research on mechanism of salvia miltiorrhiza and its chemical ingredients against liver fibrosisJournal of Chinese Integrative Medicine, 2004
- Inflammation and cancerNature, 2002
- Inhibition of Activator Protein 1 Activity by Berberine in Human Hepatoma CellsPlanta Medica, 1999
- Flowcytometric analysis of the effect of Berberine on the expression of glucocorticoid receptors in human hepatoma HepG2 cellsLife Sciences, 1994
- Effect of Magnesium Lithospermate B in Rats with Sodium-Induced Hypertension and Renal FailureNephron, 1992
- Potentiating effect of converting enzyme inhibitor captopril to the renal responses of magnesium lithospermate B in rats with adenine-induced renal failure.Chemical and Pharmaceutical Bulletin, 1991